Answers are grounded in this paper and cite their sources.
Purpose – The purpose of this paper is to focus on the adoption of the open innovation paradigm in the bio‐pharmaceutical industry and investigate through which organisational modes (e.g. collaborations, in‐ and out‐licensing) open innovation has been implemented and how these modes are interwoven with the different phases of the drug discovery and development process. Open innovation is currently one of the most debated issues in management literature. Few contributions, however, have paid attention so far to systematically and longitudinally addressing the adoption of open innovation in a specific industry.
No takes yet. Share an insight, caveat, or question.
Chiaroni et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: